trending Market Intelligence /marketintelligence/en/news-insights/trending/r2q_1npknxamvkcodmhyqw2 content esgSubNav
In This List

Brainstorm Cell Therapeutics appoints chief commercial officer

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Brainstorm Cell Therapeutics appoints chief commercial officer

New York-based biotechnology company Brainstorm Cell Therapeutics Inc. appointed Arturo Araya as chief commercial officer, effective Sept. 4.

Araya has served on Brainstorm's board since February 2017. He served as the global head of commercial for Novartis AG unit Novartis Pharmaceuticals Corp.'s cell and gene therapies unit until 2016.

Brainstorm develops stem cell treatments to treat diseases caused by degeneration of the nervous system.